Synapse - Genitourinary Oncology Service

Results (5690)

The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy

Meeting Abstract

Dotan, Z. A.; Sathyamoorthy, K.; Bianco, F. J.; Stephenson, A. J.; Eastham, J. A.; Fearn, P.; Schoder, H.; Scher, H. I.; Scardino, P. T.; Kattan, M. W.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Systems pathology for building predictive models: The androgen receptor as a prototype biomarker in prostate cancer progression and targeted therapeutic response assessment

Meeting Abstract

Donovan, M. J.; Scher, H.; Scardino, P.; Kotsianti, A.; Cordon-Cardo, C.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

SOX2 antibody responses in patients with various tumor types and SCLC with and without paraneoplastic neurologic syndromes

Meeting Abstract

Chen, L.; Narayanan, S.; Posner, J.; Ozbek, U.; Ritter, E.; Gnjatic, S.; Chen, Y.; Old, L.; Gure, A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer

Meeting Abstract

Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
EJC Supplements (2006)

Fulltext@MSK | Save

Predicting recurrence following post-chemotherapy retroperitoneal lymph node dissection for residual fibrosis or teratoma

Meeting Abstract

Carver, B. S.; Shayegan, B.; Motzer, R. J.; Bajorin, D.; Kondagunta, G. V.; Bosl, G. J.; Sheinfeld, J.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events

Meeting Abstract

Basch, E. M.; McDonough, T.; Iasonos, A.; Siegel, E.; Culkin, A.; Kris, M.; Scher, H. I.; Schrag, D.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Phase III trial of conventional-dose chemotherapy alone or with high-dose chemotherapy for metastatic germ cell tumors (GCT) patients (PTS): A cooperative group trial by Memorial Sloan-Kettering Cancer Center, ECOG, SWOG, and CALGB

Meeting Abstract

Bajorin, D. F.; Nichols, C. R.; Margolin, K. A.; Bacik, J.; Richardson, P. G.; Vogelzang, N. J.; Einhorn, L.; Mazumdar, M.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Mutational profiling of protein kinases in prostate carcinoma

Meeting Abstract

Andea, A.; Osman, I.; Scardino, P.; Scher, H.; Gerald, W.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Hypoxia response pathway markers in clear cell (conventional) renal cell carcinoma: A tissue microarray based immunohistochemical study

Meeting Abstract

Al-Ahmadie, H. A.; Tickoo, S. K.; Alden, D.; Olgac, S.; Fine, S. W.; Russo, P.; Motzer, R. J.; Reuter, V. E.
Modern Pathology (2006)

Fulltext@MSK | Save

Hypoxia response pathway markers in clear cell (conventional) renal cell carcinoma: A tissue Microarray based immunohistochemical study

Meeting Abstract

Al-Ahmadie, H. A.; Tickoo, S.; Alden, D.; Olgac, S.; Fine, S. W.; Russo, P.; Motzer, R. J.; Reuter, V. E.
Laboratory Investigation (2006)

Fulltext@MSK | Save